APA (7th ed.) Citation

Pennel, K. A. F., Hatthakarnkul, P., Wood, C. S., Lian, G., Al-Badran, S. S. F., Quinn, J. A., . . . Chang, D. K. (2024). JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors. Journal of Experimental & Clinical Cancer Research (17569966), 43(1), 1. https://doi.org/10.1186/s13046-024-02958-4

Chicago Style (17th ed.) Citation

Pennel, Kathryn A. F., et al. "JAK/STAT3 Represents a Therapeutic Target for Colorectal Cancer Patients with Stromal-rich Tumors." Journal of Experimental & Clinical Cancer Research (17569966) 43, no. 1 (2024): 1. https://doi.org/10.1186/s13046-024-02958-4.

MLA (9th ed.) Citation

Pennel, Kathryn A. F., et al. "JAK/STAT3 Represents a Therapeutic Target for Colorectal Cancer Patients with Stromal-rich Tumors." Journal of Experimental & Clinical Cancer Research (17569966), vol. 43, no. 1, 2024, p. 1, https://doi.org/10.1186/s13046-024-02958-4.